Bioasis Technologies is dedicated to delivering hope to patients suffering with neurological diseases and disorders. The Company focuses on transporting medicines across the blood-brain barrier, providing a path to address previously untreatable diseases of the central nervous system. As a preclinical biopharmaceutical company, Bioasis needed to sharpen its core story, build awareness, grow its investor base and attract high-level employees.
Wyant Simboli worked closely with Bioasis’ senior management to uncover the company’s core story and re-design its brand identity. We developed a new website and produced videos to clearly explain the problem posed by the blood-brain-barrier and the potential of the Company’s xB3 platform to deliver hope to patients suffering with neurological disease.
The refreshed brand story was presented at the Biotech Showcase in January, 2018 during the most important week in healthcare. The new branding has been an essential communications tool to increase awareness of Bioasis as the Company opened its U.S. office in Guilford, Connecticut.